WSJ Law Blog: “The big law-and-biz headline from Wednesday involved drug maker GlaxoSmithKline, which agreed to pay $750 million and enter a guilty plea to settle charges that it put bad drugs into the stream of commerce.”
Receive our latest news updates on Twitter, Facebook and your inbox.
Class Plaintiffs Obtain Final Approval of $1.51 Billion Settlement with Syngenta
Seeger Weiss LLP Welcomes Stephan J. Mallenbaum as Executive Director
Bayer to Stop Essure Birth Control Device Sales
Seeger Weiss Appointed Co-Lead in Intel CPU Litigation
Seeger Weiss Associate Honored as Cardozo Law School “Game Changer”